Biltmore Family Office’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-15,900
| Closed | -$661K | – | 167 |
|
|
2019
Q1 | $661K | Sell |
15,900
-7,300
| -31% | -$303K | 0.34% | 77 |
|
|
2018
Q4 | $850K | Sell |
23,200
-215
| -0.9% | -$7.88K | 0.48% | 63 |
|
|
2018
Q3 | $1.14M | Sell |
23,415
-335
| -1% | -$16.3K | 0.54% | 54 |
|
|
2018
Q2 | $1.02M | Sell |
23,750
-3,350
| -12% | -$144K | 0.51% | 59 |
|
|
2018
Q1 | $1.14M | Sell |
27,100
-4,550
| -14% | -$191K | 0.5% | 58 |
|
|
2017
Q4 | $1.38M | Buy |
+31,650
| New | +$1.38M | 0.62% | 51 |
|